International Journal of Advanced Science and Research

International Journal of Advanced Science and Research


International Journal of Advanced Science and Research
International Journal of Advanced Science and Research
Vol. 1, Issue 2 (2016)

Metronidazole has also been proposed as a radiation sensitizer for hypoxic cells


Partha Majumder, Anjana Mazumdar

A radio sensitizer is a drug that makes tumor cells more sensitive to radiation therapy. One of the major limitations of radiotherapy is that the cells of solid tumors become deficient in oxygen. Solid tumors can outgrow their blood supply, causing a low-oxygen state known as hypoxia. Oxygen is a potent radiosensitizer, increasing the effectiveness of a given dose of radiation by forming DNA-damaging free radicals. Tumor cells in a hypoxic environment may be as much as 2 to 3 times more resistant to radiation damage than those in a normal oxygen environment. Much research has been devoted to overcoming this problem including the use of high pressure oxygen tanks, blood substitutes that carry increased oxygen, hypoxic cell radiosensitizers such as misonidazole and metronidazole, and hypoxic cytotoxins, such as tirapazamine. A newer approach involves the use of an oxygen diffusion-enhancing compound to re-oxygenate hypoxic tumor tissue. Extensive studies show that Metronidazole increased by more than two times the radiosensitivity of cells from the central zones of the tumor and did not influence the radiation response of cells from the peripheral zones. Metronidazole was shown to inhibit the repair of potentially lethal radiation damages.
Download  |  Pages : 05-09
How to cite this article:
Partha Majumder, Anjana Mazumdar. Metronidazole has also been proposed as a radiation sensitizer for hypoxic cells. International Journal of Advanced Science and Research, Volume 1, Issue 2, 2016, Pages 05-09
International Journal of Advanced Science and Research